Agilent Technologies (NYSE:A) Downgraded by Wall Street Zen to Hold

Agilent Technologies (NYSE:A) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Several other analysts have also weighed in on A. Piper Sandler initiated coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price target for the company. Barclays lifted their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. TD Cowen increased their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, Robert W. Baird raised their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 26th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $159.35.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $138.65 on Friday. The firm has a market capitalization of $39.16 billion, a price-to-earnings ratio of 27.84, a PEG ratio of 2.48 and a beta of 1.25. Agilent Technologies has a one year low of $108.35 and a one year high of $160.27. The business has a fifty day simple moving average of $129.75 and a 200 day simple moving average of $125.55. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts expect that Agilent Technologies will post 6.01 EPS for the current year.

Institutional Investors Weigh In On Agilent Technologies

Hedge funds and other institutional investors have recently bought and sold shares of the business. SHP Wealth Management bought a new position in Agilent Technologies in the 4th quarter valued at $26,000. Core Wealth Advisors LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at about $26,000. Navalign LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at about $27,000. MV Capital Management Inc. acquired a new position in Agilent Technologies during the 4th quarter worth about $28,000. Finally, Entrust Financial LLC acquired a new position in Agilent Technologies during the 4th quarter worth about $31,000.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.